Drug Science partnership to improve patient access to medical cannabis
Drug Science Medical Cannabis Working Group has formed a partnership with a leading British producer of medical cannabis to help improve patients access to...
First study to look at the use of cannabinoids for treating acute pain
A new review has shown that further research is needed into the use of cannabinoids in the treatment of acute pain.
The only peer-reviewed journal...
Rize ETF: Europe’s most diversified cannabis equity portfolio
Four new companies have been added to Rize ETF’s specialist thematic Exchange Traded Fund (ETF) to create Europe’s most diversified cannabis equity portfolio.
Rize ETF,...
Symtomax: poised for a head start in the European cannabis market
A Portuguese cannabis company, Symtomax, is positioning itself to become the biggest supplier of medical cannabis in the European cannabis market.
Symtomax, a medical cannabis...
Expert answers: can cannabis and CBD affect coronavirus?
In this article, integrative medicine expert, Dr Dani Gordon, answers peoples’ question of whether cannabis and CBD can affect contracting or recovering from COVID-19,...
Cosaint Nectar: unleashing the power of CBDA
Cosaint Nectar CEO Philip Tarazi details the unique benefits of CBDA and how Cosaint’s industry leading innovation can support pain management.
If you have not...
Landmark move opens patient access to online cannabis consultations
Patients in the UK are one step closer to comprehensive medical cannabis access thanks to new online video consultations.
Sapphire Medical Clinics has become the...
Cymra Life Sciences: pioneering tissue culture for novel pain medicines
Cymra Life Sciences is pioneering plant science research to create superior cannabis pain relief medicines.
Australian life sciences company Cymra Life Sciences is harnessing science...
CanPharma: bridging the gap between plant and patients
With a team of medical experts and seasoned pharmaceutical entrepreneurs, CanPharma is set to drive innovation and to set new standards for optimal treatment...
CBD Export Global: streamlining global cannabis
CBD Export Global sets the international standard in sourcing, processing and supplying compliant hemp and cannabis ingredients for manufacturing consumer packaged goods.
CBD Export Global...
Arge Canna: medical cannabis lobbying and patient advocacy in Austria
Mag. Klaus Hübner of patient advocacy body Arge Canna tells MCN about Austria’s medical cannabis legislation and Arge Canna’s campaigns.
Arge Canna is the primary...
The NCIA talks policy, equality and regulation in US cannabis
National Cannabis Industry Association Media Relations Director Morgan Fox tells MCN about regulation, policy reform and representation in the field of US cannabis.
The National...
Spektrum Cannabis Technologies: making the complex simple
Spektrum Technologies eliminates the need for new facility construction and building retrofitting by housing large scale extraction equipment in transportable, regulatory compliant units.
Spektrum Cannabis...
Root Sciences: nanoemulsification and the beverage revolution
By adding nanoemulsion systems to its line of hemp and cannabis processing equipment, Root Sciences is (yet again) changing the industry’s approach to producing...
LeafCann: common misconceptions about cannabis
LeafCann Group CEO Elisabetta Faenza explores harmful myths around medical and adult use cannabis.
Leafcann is aware that perhaps no other plant causes as much...
Rize ETF: separating the medical cannabis science from the hype
Rahul Bhushan, co-founder of European exchange-traded fund issuer Rize ETF, discusses global trends in medical cannabis regulation.
The world of cannabis is full of unlikely...
Medicaleaf: the clarion call for wellness from nature
The Medicaleaf team share their observations and understanding of the driving forces of increasing consumer demand for CBD.
Medicaleaf™ aspires to be a philanthropic and...
Emerald Clinics: co-creating evidence with medical cannabis patients
Emerald Clinics CEO Dr Michael Winlo highlights the unique benefits of building real world evidence bases in patient-focussed clinical practice.
Emerald Clinics' asks 'why haven’t...
PURE5 extraction: new trends in cannabis oil production
PURE5 powered by COMERG offers innovative emerging solutions for the safe, clean extraction of high-quality cannabis product.
Cannabis oils, also called terpenes, are derived from...
The Medical Cannabis Clinics launches low cost patient access registry
The Medical Cannabis Clinics has today launched a low cost patient access registry programme for up to 5,000 medical cannabis patients.
The Medical Cannabis Clinics'...
